Rare diseases
Investigational molecules
Locations
Bulevard Vtori Yuni 68, 3000 Vratsa, Bulgaria
Complex Oncology Center Vratsa EOOD in Vratsa, Bulgaria specialises in clinical trials of conditions such as Breast cancer, Cachexia, Breast cancer metastatic, Neoplasm malignant, and other specialisations. This site conducts important research.
At Complex Oncology Center Vratsa EOOD, clinical trials in neoplasms focus strongly on breast cancer, including early, advanced, and metastatic disease. These studies are designed to evaluate new treatment options and compare them with established endocrine therapies to help reduce recurrence and improve disease control.
The research reflects a major interest in endocrine-based therapy and in finding more effective approaches for patients whose disease has progressed after prior treatment.
Another key area of work involves advanced solid tumors and broader oncology studies aimed at testing new combinations of anti-cancer therapies. These trials are focused on assessing safety, tolerability, and whether newer treatment strategies can better slow disease progression.
This line of research supports the development of more precise and effective treatment approaches for people with difficult-to-treat cancers.
The site also studies cancer cachexia, a serious metabolic complication seen in advanced cancer. Trials in this nutritional and metabolic diseases area are evaluating therapies intended to improve body weight and address the physical decline associated with cachexia.
These studies aim to improve supportive care and quality of life for patients affected by the metabolic burden of cancer.
Clinical research at this hospital and clinic setting also includes several other malignancies, with attention to treatment options for prostate cancer, small cell lung cancer, and lymphoma. The trials are exploring whether new therapies can benefit patients with relapsed, refractory, or treatment-resistant disease.
These investigations broaden the center’s oncology portfolio and support efforts to improve outcomes across several aggressive cancer types.
Clinical trials currently enrolling participants at this site.
A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
BulgariaBulgariaStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
BulgariaStudy of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels
BulgariaStudy Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment
BulgariaContinued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies
BulgariaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
